GlassVC
No published image.

Julie Papanek Grant

General Partner · Canaan Partners

General PartnerMenlo Park, CA

Julie Papanek Grant is a general partner at Canaan, where she has led biopharma investments and company formation since 2013, incubating companies including Day One Biopharmaceuticals, which she co-founded and formerly led as CEO. Her investments have included Protagonist Therapeutics, CytomX and Synthekine, and the exited Cellular Research and Labrys Biologics. Previously at Genentech in oncology business development and commercial roles, she serves on the National Cancer Advisory Board and holds an MBA from Stanford GSB, an M.Phil. from Cambridge and a B.S. from Yale.

Board seats

11 current

· PUBLIC SOURCES

Credited hits

6

· PUBLIC SOURCES

Midas years

No public record

LAST CHECKED NOV 2026

Founder rating

No public record

LAST CHECKED NOV 2026

Maintained from public sources. Not claimed. If you're Julie Papanek Grant, you can claim this profile.

Claim this profileHow claiming works

Claiming verifies identity and affiliation. It does not permit editing reviews, scores, or cited facts.

Track record

Credited deals only — Julie Papanek Grant is named in a public source as investor, lead, or board member on these deals. This is not a complete investment history, and absence here is not evidence of absence.
  • Day One Biopharmaceuticalsacquired

    Co-founded and incubated at Canaan by Julie Papanek Grant; public company (NASDAQ: DAWN) acquired by Servier, per Crunchbase.

    Source: crunchbase.com

  • Cellular Researchacquired

    Acquired by Becton Dickinson; listed among Julie Grant's investments on her Canaan bio.

    Source: canaan.com

  • Labrys Biologicsacquired

    Acquired by Teva; listed among Julie Grant's investments on her Canaan bio.

    Source: canaan.com

  • Protagonist Therapeuticsipo

    Public company (PTGX); listed among Julie Grant's investments on her Canaan bio.

    Source: canaan.com

  • CytomX Therapeuticsipo

    Public company (CTMX); listed among Julie Grant's investments on her Canaan bio.

    Source: canaan.com

  • Dermiraipo

    Public company (DERM); listed among Julie Grant's investments on her Canaan bio.

    Source: canaan.com

Board seats

Current board seats · 1

Success signals

Forbes Midas List

No public record

Not listed.

Reputation

No reputation score — basis not established for this investor.

No reputation sources on file yet.

Suggest a source

Contact

Published sources only

Published contact details collected from public sources. Not a referral, and not an introduction.

Published contact

Published sources only

GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.

Claimed profiles can replace or remove contact details.

What founders say

Founder-submitted · Verified identity and relationship

No founder reviews yet

Be the first founder to share your experience with Julie Papanek Grant. Reviews come from founders whose identity and relationship have been verified.

Write the first review
Reviews of Canaan Partners (0) →

Firm-level reviews are not attributed to Julie Papanek Grant.

Methodology

This profile carries no tier: tier belongs to the firm and is shown only via the linked firm name — never inherited onto a person.

Credited deals, board seats, Midas years and reputation links are carried per investor in the catalog, each item with the public source it was credited from, linked from the sections above. Fields with no sourced record render their honest null states, and every published field traces to the catalog record listed below. Review dimension scores appear only at three or more reviews.

Corrections with a source: Suggest a correction.

Source record 1

  1. [1]

    DATABASE · GlassVC catalog — Catalog record for Julie Papanek Grant — provenance: GlassVC catalog

    CATALOG SOURCE FIELD · LAST CHECKED NOV 2026

    ↩ cites: Title · Firm · Type · Bio · Location · Focus · Credited deals · Board seats

EVERY FIGURE ON THIS PAGE IS TRACEABLE TO THE CATALOG RECORD ABOVE · LAST CHECKED NOV 2026